No brain differences found in cannabis users across risk levels

No differences in inhibitory control or prefrontal activation during a cannabis cue stop-signal task across CUDIT-R-defined CUD-risk groups.

Psychopharmacology • • Moderately Relevant
🤖

AI Summary

This study examined whether heavy cannabis users show different brain activation and decision-making abilities compared to lighter users and non-users. Researchers recruited 81 participants divided into three groups based on cannabis use patterns: high-risk users (those scoring ≥12 on the CUDIT-R assessment), low-risk users (scores <8), and non-users. All participants completed a specialized cannabis-cue Stop-Signal Task while researchers measured brain activity in the prefrontal cortex—the region responsible for impulse control and decision-making—using advanced neuroimaging technology called functional near-infrared spectroscopy (fNIRS).

Surprisingly, the researchers found no significant differences in inhibitory control performance or brain activation patterns between the three groups. Participants in all groups performed similarly on the task and showed comparable levels of prefrontal and orbitofrontal activation. This contradicts some previous research suggesting that heavy cannabis users develop impaired impulse control. The study was careful to exclude anyone with an actual cannabis use disorder diagnosis, examining only those without clinical-level problems, which may explain why differences weren't detected.

The findings suggest that problematic cannabis use patterns may not necessarily result in measurable deficits in inhibitory control at the neural level, at least not in individuals without a formal cannabis use disorder diagnosis. However, the researchers recommend that future studies use more sophisticated diagnostic categories, multiple imaging techniques, and real-world assessment methods to better understand how cannabis affects the brain. This work highlights the complexity of cannabis neurobiology and the importance of distinguishing between recreational use and true addiction when studying brain changes.

📄 Original Abstract

Cannabis use continues to increase globally, with a growing proportion of users exhibiting problematic patterns of use. Although neural differences in reward and inhibitory control systems are commonly reported in individuals who use cannabis relative to individuals not reporting cannabis use, findings using behavioural tasks are inconsistent. This is possibly due to lack of differentiation between regular and more problematic patterns of use. This study investigated whether inhibitory control performance and associated prefrontal and orbitofrontal activation differed across CUDIT-R-stratified levels of CUD risk. Participants (N = 81) were divided into three groups based on CUDIT-R scores: 30 high-CUD-risk individuals who use cannabis (≥ 12), 21 low-CUD-risk individuals who use cannabis (< 8), and 30 individuals not reporting cannabis use. Individuals with a current substance use disorder, including cannabis use disorder, were excluded from participation. All completed a cannabis-cue specific Stop-Signal Task (SST) while functional near-infrared spectroscopy (fNIRS) was used to measure oxygenated (oxyHb) and deoxygenated haemoglobin (deoxyHb) concentrations in the prefrontal cortices. Behavioural performance and neural activation were compared across groups. No significant behavioural or neural differences were found between the groups. The study found no evidence of impaired inhibitory control or differential prefrontal activation across CUDIT-R-stratified levels of CUD risk. The results suggest incorporating further diagnostic stratification, multimodal imaging, and ecologically valid methods in future research to better characterise cannabis-related neural adaptations and inform clinical practice.

Explore More Research

Stay informed about the latest cannabis science.

Your stash, decoded.